GlaxoSmithKline (GSK)

All online trades £12.50 plus an annual Management Fee of £35 & VAT with Selftrade. Apply

1,421.50p
   
  • Change Today:
    -2.00p
  • 52 Week High: 1,497.00p
  • 52 Week Low: 1,205.00p
  • Currency: UK Pounds
  • Shares Issued: 5,036m
  • Volume: 7,337,610
  • Market Cap: £71,582m
  • RiskGrade: 74
  • Beta: 0.52

GlaxoSmithKline Overview

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

1 Day Chart (16-05-2012)

6 Month Chart

Financials

Latest F'cast
Div Yield 4.9% 5.2%
Div Cover 1.6 1.6
Op Mrgn 28.5% 30.2%
ROCE 62.3%  
Latest F'cast
P/E 12.5 11.6
PEG 0.1 1.7
Pr/Revenue 2.6 2.6
Pr/Book 8.1  
Latest F'cast
Revenue -3.5% 2.0%
PBT 143.8% 9.4%
EPS 111.7% 7.0%
DPS 7.7% 6.2%

GlaxoSmithKline Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-07 22,716.00 7,452.00 99.10p 12.9 3.2 +4% 53.00p 4.1%
31-Dec-08 24,352.00 6,659.00 104.70p 12.3 2.0 +6% 57.00p 4.4%
31-Dec-09 28,368.00 7,891.00 121.20p 10.9 0.7 +16% 61.00p 4.6%
31-Dec-10 28,392.00 3,157.00 53.90p 23.0 n/a -56% 65.00p 5.2%
31-Dec-11 27,387.00 7,698.00 114.10p 12.9 0.1 +112% 70.00p 4.8%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GlaxoSmithKline Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-12 27,930.31 8,422.47 122.11p 11.6 1.7 +7% 74.32p 5.2%
31-Dec-13 28,861.17 8,854.21 131.86p 10.8 1.4 +8% 79.11p 5.6%

Copyright © 2012 FactSet Research Systems Inc. All rights reserved.

GlaxoSmithKline Company Announcements

Director Declaration 16-May-2012 17:20 RNS
Transaction in Own Shares 16-May-2012 17:15 RNS
GSK increases its ownership in Theravance 16-May-2012 14:12 RNS

GlaxoSmithKline ShareCast News

Glaxo to take full control of Cellzome 15-May-2012 ShareCast
London midday: Stocks tank again on euro worries 09-May-2012 ShareCast
London open: Stocks claw back after heavy sell-off 09-May-2012 ShareCast

GlaxoSmithKline Top Newspaper Links

GLAXO GOES HOSTILE IN BID 10-May-2012 Express & Star
Glaxo wins £1.5m grant 20-Dec-2011 The Herald
GSK embarks on a new age of discovery 12-Dec-2011 Telegraph

Latest GlaxoSmithKline Director Deals

Traded Action Notifier PriceAmountValue
10-May-12 Transfer From Simon Dingemans 0.000p 9 £0.00
10-May-12 Buy Simon Dingemans 1,407.36p 9 £126.66
10-May-12 Transfer From Andrew P Witty 0.000p 9 £0.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

GlaxoSmithKline Market Data

Currency UK Pounds
Share Price 1,421.50p
Change Today -2.00p
% Change -0.14 %
52 Week High 1,497.00p
52 Week Low 1,205.00p
Volume 7,337,610
Shares Issued 5,036m
Market Cap £71,582m
Beta 0.52
RiskGrade 74

GlaxoSmithKline Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
6.28% below the market average6.28% below the market average6.28% below the market average6.28% below the market average6.28% below the market average
65.22% above the sector average65.22% above the sector average65.22% above the sector average65.22% above the sector average65.22% above the sector average
Price Trend
61.66% above the market average61.66% above the market average61.66% above the market average61.66% above the market average61.66% above the market average
32.14% above the sector average32.14% above the sector average32.14% above the sector average32.14% above the sector average32.14% above the sector average
Income
71.84% above the market average71.84% above the market average71.84% above the market average71.84% above the market average71.84% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average
Growth
58.31% above the market average58.31% above the market average58.31% above the market average58.31% above the market average58.31% above the market average
55.10% above the sector average55.10% above the sector average55.10% above the sector average55.10% above the sector average55.10% above the sector average

What The Brokers Say

Strong Buy 12
Buy 3
Neutral 17
Sell 3
Strong Sell 0
Total 35
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GlaxoSmithKline Dividends

  Latest Previous
  Q1 Special
Ex-Div 09-May-12 15-Feb-12
Paid 05-Jul-12 12-Apr-12
Amount 17.00p 5.00p

Trades for 16-May-2012

Time Volume / Share Price
16:51 5,600 @ 1,421.15p
16:46 435 @ 1,424.00p
16:44 4,003 @ 1,421.25p
16:42 3,000 @ 1,422.06p
16:36 2,500 @ 1,421.50p

GlaxoSmithKline Key Personnel

CEO Andrew P Witty

Top of Page